BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 31870092)

  • 21. A diterpenoid compound, excisanin A, inhibits the invasive behavior of breast cancer cells by modulating the integrin β1/FAK/PI3K/AKT/β-catenin signaling.
    Qin J; Tang J; Jiao L; Ji J; Chen WD; Feng GK; Gao YH; Zhu XF; Deng R
    Life Sci; 2013 Nov; 93(18-19):655-63. PubMed ID: 24044886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Basic fibroblast growth factor promotes melanocyte migration via activating PI3K/Akt-Rac1-FAK-JNK and ERK signaling pathways.
    Shi H; Lin B; Huang Y; Wu J; Zhang H; Lin C; Wang Z; Zhu J; Zhao Y; Fu X; Lou Z; Li X; Xiao J
    IUBMB Life; 2016 Sep; 68(9):735-47. PubMed ID: 27350596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tetrandrine inhibits migration and invasion of rheumatoid arthritis fibroblast-like synoviocytes through down-regulating the expressions of Rac1, Cdc42, and RhoA GTPases and activation of the PI3K/Akt and JNK signaling pathways.
    Lv Q; Zhu XY; Xia YF; Dai Y; Wei ZF
    Chin J Nat Med; 2015 Nov; 13(11):831-841. PubMed ID: 26614458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of the GTPase Rac1 mediates the antimigratory effects of metformin in prostate cancer cells.
    Dirat B; Ader I; Golzio M; Massa F; Mettouchi A; Laurent K; Larbret F; Malavaud B; Cormont M; Lemichez E; Cuvillier O; Tanti JF; Bost F
    Mol Cancer Ther; 2015 Feb; 14(2):586-96. PubMed ID: 25527635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Zoledronate inhibits endothelial cell adhesion, migration and survival through the suppression of multiple, prenylation-dependent signaling pathways.
    Hasmim M; Bieler G; Rüegg C
    J Thromb Haemost; 2007 Jan; 5(1):166-73. PubMed ID: 17059425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simulated microgravity inhibits the viability and migration of glioma via FAK/RhoA/Rock and FAK/Nek2 signaling.
    Deng B; Liu R; Tian X; Han Z; Chen J
    In Vitro Cell Dev Biol Anim; 2019 Apr; 55(4):260-271. PubMed ID: 30820814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Maspin controls mammary tumor cell migration through inhibiting Rac1 and Cdc42, but not the RhoA GTPase.
    Shi HY; Stafford LJ; Liu Z; Liu M; Zhang M
    Cell Motil Cytoskeleton; 2007 May; 64(5):338-46. PubMed ID: 17301947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PI3K/Akt-dependent phosphorylation of GSK3β and activation of RhoA regulate Wnt5a-induced gastric cancer cell migration.
    Liu J; Zhang Y; Xu R; Du J; Hu Z; Yang L; Chen Y; Zhu Y; Gu L
    Cell Signal; 2013 Feb; 25(2):447-56. PubMed ID: 23123500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spike formation by fibroblasts adhering to fibrillar collagen I gel.
    Sato K; Hattori S; Irie S; Kawashima S
    Cell Struct Funct; 2003 Aug; 28(4):229-41. PubMed ID: 14586133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin-8 induces the endothelial cell migration through the Rac 1/RhoA-p38MAPK pathway.
    Lai Y; Liu XH; Zeng Y; Zhang Y; Shen Y; Liu Y
    Eur Rev Med Pharmacol Sci; 2012 May; 16(5):630-8. PubMed ID: 22774404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progesterone Inhibits Endothelial Cell Migration Through Suppression of the Rho Activity Mediated by cSrc Activation.
    Lee TS; Lin JJ; Huo YN; Lee WS
    J Cell Biochem; 2015 Jul; 116(7):1411-8. PubMed ID: 25754581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enterolactone alters FAK-Src signaling and suppresses migration and invasion of lung cancer cell lines.
    Chikara S; Lindsey K; Borowicz P; Christofidou-Solomidou M; Reindl KM
    BMC Complement Altern Med; 2017 Jan; 17(1):30. PubMed ID: 28068967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The G12/13-RhoA signaling pathway contributes to efficient lysophosphatidic acid-stimulated cell migration.
    Bian D; Mahanivong C; Yu J; Frisch SM; Pan ZK; Ye RD; Huang S
    Oncogene; 2006 Apr; 25(15):2234-44. PubMed ID: 16301993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypoxia stimulates invasion and migration of human cervical cancer cell lines HeLa/SiHa through the Rab11 trafficking of integrin αvβ3/FAK/PI3K pathway-mediated Rac1 activation.
    Xu H; Yuan Y; Wu W; Zhou M; Jiang Q; Niu L; Ji J; Liu N; Zhang L; Wang X
    J Biosci; 2017 Sep; 42(3):491-499. PubMed ID: 29358562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dexamethasone disrupts cytoskeleton organization and migration of T47D Human breast cancer cells by modulating the AKT/mTOR/RhoA pathway.
    Meng XG; Yue SW
    Asian Pac J Cancer Prev; 2014; 15(23):10245-50. PubMed ID: 25556455
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PCTK3/CDK18 regulates cell migration and adhesion by negatively modulating FAK activity.
    Matsuda S; Kawamoto K; Miyamoto K; Tsuji A; Yuasa K
    Sci Rep; 2017 Mar; 7():45545. PubMed ID: 28361970
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Theanine from tea and its semi-synthetic derivative TBrC suppress human cervical cancer growth and migration by inhibiting EGFR/Met-Akt/NF-κB signaling.
    Liu J; Sun Y; Zhang H; Ji D; Wu F; Tian H; Liu K; Zhang Y; Wu B; Zhang G
    Eur J Pharmacol; 2016 Nov; 791():297-307. PubMed ID: 27612630
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of artonin e on migration and invasion capabilities of human lung cancer cells.
    Plaibua K; Pongrakhananon V; Chunhacha P; Sritularak B; Chanvorachote P
    Anticancer Res; 2013 Aug; 33(8):3079-88. PubMed ID: 23898063
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metformin, a first-line drug for type 2 diabetes mellitus, disrupts the MALAT1/miR-142-3p sponge to decrease invasion and migration in cervical cancer cells.
    Xia C; Liang S; He Z; Zhu X; Chen R; Chen J
    Eur J Pharmacol; 2018 Jul; 830():59-67. PubMed ID: 29704494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibitory effect of capsaicin on B16-F10 melanoma cell migration via the phosphatidylinositol 3-kinase/Akt/Rac1 signal pathway.
    Shin DH; Kim OH; Jun HS; Kang MK
    Exp Mol Med; 2008 Oct; 40(5):486-94. PubMed ID: 18985006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.